Transaction · 0001493152-26-043383

Huntsman Ronald Kirk

Huntsman Ronald Kirk, CEO, reported a transaction classified as other at Vivos Therapeutics, Inc. involving 85910.000000 shares for an estimated $49999.62. Reported holdings after the transaction were 85910.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

otherSEC transaction code JCEO
VVOSVivos Therapeutics, Inc.
Trade date
Jun 30, 2026
Filing date
Sep 18, 2026
View on SEC Insider profile
Disclosed value$49.9kShares × reported price
Shares traded85.9k$0.58 per share
Holdings after85.9kIndirect · See footnote
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
2 warnings
delayed filingThe filing was reported 80 calendar days after the transaction date.
ambiguous transaction codeThe transaction code is missing or represents other activity; review the filing and footnotes.

VVOS price since this filing

Daily closing prices, with the filing date and available return windows
VVOS · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d -12.5%30d -18.8%90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
other
Code J
Identifier
0001493152-26-043383
Warrant (Right to Buy)
Transaction date
Jun 30, 2026
Filed Sep 18, 2026, 09:04 PM · 80d delay
Shares
85,910 sh
$0.58 per share
Estimated value
$49.9k
Computed from shares × price
Holdings after
85,910 sh
Indirect · See footnote

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Delayed Filing Derivative Transaction Large Holdings Increase
Filing-only score

-22 points

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

How this score is calculated
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
  • delayed_filing-6 points

    reporting_delay_days = 80

    Filing delay exceeds the configured threshold.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Executive Officer

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Shares held by Coronado V Partners, LLC, of which the Reporting Person is a member and manager.

  2. F2

    On June 30, 2026, the Reporting Person participated in the PIPE Offering indirectly through V-Co Investors 4 LLC ("V-Co 4"), in which he acquired a membership interest. His indirect interest in V-Co 4…

  3. F3

    Represents employee stock options granted on various dates, with exercise prices ranging from $2.38 to $81.75 and expiration dates ranging from February 25, 2027 to September 7, 2034, and also reflect…

Original filing · 0001493152-26-043383
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

VVOS